InsidersTradesSigma
Track the 永安药业 stock price and the full management transaction log of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 永安药业 has recorded 1 insider filings. Market capitalisation: €3.4bn. The latest transaction was filed on 1 December 2025 (Sale). Among the most active insiders: 方锡权. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
永安药业是一家在XSHE市场上市的健康和制药公司。它专注于创新药物的研发和生产。